Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) Return on Capital Employed (2016 - 2025)

Utah Medical Products has reported Return on Capital Employed over the past 15 years, most recently at 0.02% for Q4 2025.

  • Quarterly results put Return on Capital Employed at 0.02% for Q4 2025, down 9.0% from a year ago — trailing twelve months through Dec 2025 was 0.02% (down 9.0% YoY), and the annual figure for FY2025 was 0.02%, changed 0.0%.
  • Return on Capital Employed for Q4 2025 was 0.02% at Utah Medical Products, down from 0.1% in the prior quarter.
  • Over the last five years, Return on Capital Employed for UTMD hit a ceiling of 0.18% in Q3 2022 and a floor of 0.0% in Q3 2024.
  • Median Return on Capital Employed over the past 5 years was 0.11% (2025), compared with a mean of 0.1%.
  • Biggest five-year swings in Return on Capital Employed: decreased -15bps in 2021 and later rose 16bps in 2022.
  • Utah Medical Products' Return on Capital Employed stood at 0.17% in 2021, then increased by 4bps to 0.17% in 2022, then tumbled by -89bps to 0.02% in 2023, then surged by 509bps to 0.11% in 2024, then tumbled by -81bps to 0.02% in 2025.
  • The last three reported values for Return on Capital Employed were 0.02% (Q4 2025), 0.1% (Q3 2025), and 0.11% (Q2 2025) per Business Quant data.